What's Shai Pines's mailing address?
Shai's mailing address filed with the SEC is 3 SMADAR ST., , SAVION, L3, 56546.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Pluri Inc
Over the last 17 years, insiders at Pluri Inc have traded over $7,081,854 worth of Pluri Inc stock and bought 2,345,914 units worth $14,327,834 . The most active insiders traders include Wolf Capital Limited Part..., Zami Aberman y Israel Ben Yoram. On average, Pluri Inc executives and independent directors trade stock every 64 days with the average trade being worth of $54,123. The most recent stock trade was executed by Zami Aberman on 10 February 2022, trading 80,616 units of PSTI stock currently worth $145,109.
What does Pluri Inc do?
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a
What does Pluri Inc's logo look like?
Pluri Inc executives and stock owners
Pluri Inc executives and other stock owners filed with the SEC include:
-
Yaacov Yanay,
Pres, CEO & Director -
Zalman Aberman,
Executive Chairman of the Board -
Yaky Yanay,
President, Chief Executive Officer, Director -
Chen Franco-Yehuda,
Chief Financial Officer, Treasurer, Secretary -
Dana Rubin,
Director of Investor Relations -
Moria Kwiat,
Independent Director -
Mark Germain,
Independent Director -
Isaac Braun,
Independent Director -
Doron Shorrer,
Lead Independent Director -
Dr. Nitsan Halevy M.D.,
Chief Medical Officer -
Efrat Livne-Hadass,
VP of HR -
Lior Raviv,
Chief Technology Officer -
Israel Ben Yoram,
Director -
Nachum Rosman,
Director -
Hava Meretzki,
Director -
Erez Egozi,
Chief Financial Officer -
Shai Pines,
Director -
Boaz Gur Lavie,
CFO -
Wolf Capital Limited Part...,
10% owner -
Maital Shemesh Rasmussen,
Director -
Rami Avraham Levi,
Director -
Pinhas Doron Birger,
Director -
Varda Shalev,
Director -
Zami Aberman,
Director